Blog / Archives
Innovation Drives Market Gains in Biopharmaceuticals
This article was published in Genetic Engineering News in the section "Wall Street Biobeat" on April 1, 2011. Monoclonal antibody therapies remain the dominant technology with immunotherapy and stem...
Decent Follow Through From Yesterday’s Biotech Rally
Biopharmaceutical stocks caught bids today (in a weak technology market) after yesterday's M&A spiked rally. Large cap leaders in the NASDAQ-100 were up: Biogen(BIIB) up 1.63%, Celgene (CELG) up...
Caution on Optimer (OPTR) Down 3% in Strong Biotech Market-update April 1 OPTR up 11%
Optimer soars 11% to $13.13 on presentation of Shea Data and preliminary FDA review: Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile...
Biotech Sector Soars On Valeant (VRX) Bid For Cephalon (CEPH)
Biopharmaceutical Stocks Ignited By M&A Potential M&A has been a key driver for investing in biotech stocks as need for product pipeline and technologies grows. The drug development process...
Rayno Life Science Portfolio: Cephalon (CEPH) Up 27% After Hours on Valeant (VRX) Hostile Bid- UPDATE
3/30/11 Update CEO Michael Pearson of Canadian based Valeant (VRX) reiterated his determination(live on CNBC this am) for buying Cephalon (CEPH) after being stalled by the Board of CEPH after...
Rayno Life Science Portfolio Up 1.3% In A Strong NASDAQ Market
As has been the pattern lately biotech sector rallies coincide with NASDAQ with the NAZ (2753) up 20.2 or 0.81% . The mid caps are the sweet spot in the market with as our mid-cap index of 33...
Technology Convergence in Healthcare: Abbott (ABT), Alere (ALR) and Merge (MRGE)
In January we reported from the JPMorgan Healthcare Conference regarding convergence of communications and medical technologies. Two trends mentioned were use of cloud computing and connectivity in...
Ariad (ARIA) and MolecularMD Collaborate in Companion Dx for CML
Ariad (ARIA $7.24 up 4.3%) continues to roll on today on heavy volume up 17% over 5 days on speculation, news and upgrades with strong expectations for their chronic myeloid leukemia drug ponatinib....
Why is the Market Going Up?
Rick Santelli on CNBC answered the question today. Very few places to put your money: 1-In the mattress-cash. 2-In the ground-metals, energy. 3-In equities-earnings. With investors worried about...
Stocks to Watch-Life Science Tools and Diagnostics: Meridian(VIVO) and IRIS
On robust and active Life Science trading day two laggard diagnostic stocks perked up: Iris International (IRIS $9.41) is up 4.44% on FDA clearance of its iChem Velocity Workstation for automated...